- Home
- GDTC vs BNR Comparison
GDTC vs BNR Comparison
Compare GDTC & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- BNR
- Stock Information
- Founded
- GDTC 2018
- BNR 2014
- Country
- GDTC Singapore
- BNR China
- Employees
- GDTC N/A
- BNR N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- BNR Medical Specialities
- Sector
- GDTC Health Care
- BNR Health Care
- Exchange
- GDTC Nasdaq
- BNR Nasdaq
- Market Cap
- GDTC 25.1M
- BNR 28.6M
- IPO Year
- GDTC 2023
- BNR 2020
- Fundamental
- Price
- GDTC $2.17
- BNR $3.77
- Analyst Decision
- GDTC Buy
- BNR
- Analyst Count
- GDTC 1
- BNR 0
- Target Price
- GDTC $5.00
- BNR N/A
- AVG Volume (30 Days)
- GDTC 22.4K
- BNR 21.0K
- Earning Date
- GDTC 01-01-0001
- BNR 11-29-2024
- Dividend Yield
- GDTC N/A
- BNR N/A
- EPS Growth
- GDTC N/A
- BNR N/A
- EPS
- GDTC N/A
- BNR N/A
- Revenue
- GDTC $330,254.00
- BNR $70,154,674.00
- Revenue This Year
- GDTC $14.71
- BNR $52.90
- Revenue Next Year
- GDTC N/A
- BNR $48.35
- P/E Ratio
- GDTC N/A
- BNR N/A
- Revenue Growth
- GDTC N/A
- BNR N/A
- 52 Week Low
- GDTC $1.20
- BNR $2.62
- 52 Week High
- GDTC $5.50
- BNR $9.99
- Technical
- Relative Strength Index (RSI)
- GDTC 47.02
- BNR 61.38
- Support Level
- GDTC $2.11
- BNR $2.65
- Resistance Level
- GDTC $2.60
- BNR $3.89
- Average True Range (ATR)
- GDTC 0.33
- BNR 0.30
- MACD
- GDTC -0.07
- BNR 0.12
- Stochastic Oscillator
- GDTC 34.42
- BNR 90.32
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.